Original Research
Published on 18 Jul 2014
SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy
in Pediatric Oncology
Frontiers in Pediatrics
doi 10.3389/fped.2014.00075
- 8,281 views
- 16 citations